ISGE Congress session reviews personalised endometriosis treatments

4 articles · Updated · emjreviews.com · Apr 30

At the 2026 meeting, speakers from Italy, Switzerland and Türkiye said care should vary by symptoms, age, menopause stage and pregnancy plans, covering drugs, surgery and assisted reproduction.
Hormonal therapy was presented as first-line for pain without pregnancy goals, while surgery was reserved for failed medical treatment, obstruction, suspected cancer or selected fertility-sparing cases.
The session also addressed postmenopausal disease, cancer and cardiovascular risk assessment, and evidence gaps, noting a lack of double-blind randomised trials despite long-term observational support for some treatments.

As laparoscopy is sidelined, can new imaging tech finally offer women a swift, non-invasive endometriosis diagnosis?

With 37 new genes linked to endometriosis, are we on the verge of developing a non-hormonal cure for the disease?

Endometriosis is linked to heart disease. What other whole-body health risks does this systemic inflammatory condition pose for patients?